These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 34072345)

  • 21. Epithelial-to-mesenchymal transition in tumor progression.
    Prieto-García E; Díaz-García CV; García-Ruiz I; Agulló-Ortuño MT
    Med Oncol; 2017 Jul; 34(7):122. PubMed ID: 28560682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell Plasticity and Prostate Cancer: The Role of Epithelial-Mesenchymal Transition in Tumor Progression, Invasion, Metastasis and Cancer Therapy Resistance.
    Papanikolaou S; Vourda A; Syggelos S; Gyftopoulos K
    Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34199763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L
    Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073
    [No Abstract]   [Full Text] [Related]  

  • 24. Epithelial-mesenchymal plasticity (EMP) in wound healing: Exploring EMT mechanisms, regulatory network, and therapeutic opportunities.
    Yao W; Wang Z; Ma H; Lin Y; Liu X; Li P; He X
    Heliyon; 2024 Jul; 10(14):e34269. PubMed ID: 39108889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity.
    Skrypek N; Goossens S; De Smedt E; Vandamme N; Berx G
    Trends Genet; 2017 Dec; 33(12):943-959. PubMed ID: 28919019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of partial EMT in cancer progression.
    Saitoh M
    J Biochem; 2018 Oct; 164(4):257-264. PubMed ID: 29726955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Insights Into the Role of Phenotypic Plasticity and EMT in Driving Cancer Progression.
    Bhatia S; Wang P; Toh A; Thompson EW
    Front Mol Biosci; 2020; 7():71. PubMed ID: 32391381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NRF2-dependent Epigenetic Regulation can Promote the Hybrid Epithelial/Mesenchymal Phenotype.
    Jia W; Jolly MK; Levine H
    Front Cell Dev Biol; 2021; 9():828250. PubMed ID: 35118079
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Canciello A; Cerveró-Varona A; Peserico A; Mauro A; Russo V; Morrione A; Giordano A; Barboni B
    Front Cell Dev Biol; 2022; 10():1038841. PubMed ID: 36467417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slug and E-Cadherin: Stealth Accomplices?
    Sterneck E; Poria DK; Balamurugan K
    Front Mol Biosci; 2020; 7():138. PubMed ID: 32760736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Computational Systems Biology Approach Identifies SLUG as a Mediator of Partial Epithelial-Mesenchymal Transition (EMT).
    Subbalakshmi AR; Sahoo S; Biswas K; Jolly MK
    Cells Tissues Organs; 2022; 211(6):689-702. PubMed ID: 33567424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Harnessing Carcinoma Cell Plasticity Mediated by TGF-β Signaling.
    Wang X; Thiery JP
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epithelial-Mesenchymal Plasticity and Endothelial-Mesenchymal Transition in Cutaneous Wound Healing.
    Vu R; Dragan M; Sun P; Werner S; Dai X
    Cold Spring Harb Perspect Biol; 2023 Aug; 15(8):. PubMed ID: 36617638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NFATc Acts as a Non-Canonical Phenotypic Stability Factor for a Hybrid Epithelial/Mesenchymal Phenotype.
    Subbalakshmi AR; Kundnani D; Biswas K; Ghosh A; Hanash SM; Tripathi SC; Jolly MK
    Front Oncol; 2020; 10():553342. PubMed ID: 33014880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial-mesenchymal plasticity in cancer: signaling pathways and therapeutic targets.
    Wang X; Xue X; Pang M; Yu L; Qian J; Li X; Tian M; Lyu A; Lu C; Liu Y
    MedComm (2020); 2024 Aug; 5(8):e659. PubMed ID: 39092293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hybrid Epithelial-Mesenchymal Phenotypes Are Controlled by Microenvironmental Factors.
    Selvaggio G; Canato S; Pawar A; Monteiro PT; Guerreiro PS; Brás MM; Janody F; Chaouiya C
    Cancer Res; 2020 Jun; 80(11):2407-2420. PubMed ID: 32217696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epithelial-mesenchymal transition in gastric cancer.
    Huang L; Wu RL; Xu AM
    Am J Transl Res; 2015; 7(11):2141-58. PubMed ID: 26807164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival.
    Grosse-Wilde A; Fouquier d'Hérouël A; McIntosh E; Ertaylan G; Skupin A; Kuestner RE; del Sol A; Walters KA; Huang S
    PLoS One; 2015; 10(5):e0126522. PubMed ID: 26020648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic Plasticity and Cancer: A System Biology Perspective.
    Subbalakshmi AR; Ramisetty S; Mohanty A; Pareek S; Do D; Shrestha S; Khan A; Talwar N; Tan T; Vishnubhotla P; Singhal SS; Salgia R; Kulkarni P
    J Clin Med; 2024 Jul; 13(15):. PubMed ID: 39124569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EMT/MET plasticity in cancer and Go-or-Grow decisions in quiescence: the two sides of the same coin?
    Akhmetkaliyev A; Alibrahim N; Shafiee D; Tulchinsky E
    Mol Cancer; 2023 May; 22(1):90. PubMed ID: 37259089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.